Date: June 10, 2026 l Reporter: Kimberly White
PRAGUE, Czech Republic — A U.S. doctor who was transferred from Uganda to the Czech Republic for precautionary Ebola monitoring has been released from hospital after completing the observation period without developing symptoms and is now returning home.
The physician, identified in media reports as Patrick LaRochelle, had been receiving care and observation at Prague’s Bulovka Hospital since May 21 after coming into contact with an Ebola patient while working in Uganda. Hospital officials confirmed Wednesday that the monitoring period ended without signs of infection.
According to Czech health authorities, the transfer was carried out at the request of U.S. officials, who selected the facility because of its experience and capabilities in handling highly infectious diseases. The doctor remained in isolation for approximately three weeks to complete the standard incubation monitoring process.
Hospital officials stated that throughout the observation period, the doctor showed no symptoms associated with Ebola and required no active treatment. His release means health teams no longer consider him at risk of developing illness linked to the exposure event.
The case unfolded during an ongoing Ebola outbreak centred in eastern Democratic Republic of Congo, with related cases also reported in neighbouring Uganda. Global health agencies continue efforts to contain the spread of the virus while strengthening preparedness measures in surrounding countries.
Public health authorities have emphasized that monitoring and precautionary isolation remain standard tools for managing exposure to highly infectious diseases and do not necessarily indicate that an individual is infected. According to the U.S. Centers for Disease Control and Prevention, no Ebola cases connected to the current outbreak have been confirmed inside the United States and overall public risk remains low.
The release comes amid broader international efforts to contain the outbreak, which has prompted countries to increase surveillance, travel screening, and cross-border coordination to reduce the risk of transmission while protecting healthcare workers responding on the front lines.